Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Cognitive and Neurophysiological Effects of Raloxifene in Alzheimer's Disease

Authors not listed

University of Wisconsin, Madison · 2001

Abstract

The aim of this study is to determine the effectiveness of treatment with raloxifene, an estrogen-like medication approved by the Food and Drug Administration for the treatment of osteoporosis, in improving memory and the ability to live independently in postmenopausal women with Alzheimer's disease.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-11 MST

Cite this

APA
Anonymous. (2001). Cognitive and Neurophysiological Effects of Raloxifene in Alzheimer's Disease. <em>University of Wisconsin, Madison</em>. https://clinicaltrials.gov/study/NCT00065767
Vancouver
Anonymous. Cognitive and Neurophysiological Effects of Raloxifene in Alzheimer's Disease. University of Wisconsin, Madison. 2001.
BibTeX
@misc{anon2001Cognit, title = {Cognitive and Neurophysiological Effects of Raloxifene in Alzheimer's Disease}, author = {Anonymous}, journal = {University of Wisconsin, Madison}, year = {2001}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings